Search Results - John Wrangle
- Showing 1 - 5 results of 5
-
1
-
2
IL-15: from discovery to FDA approval by Zihai Li, John Wrangle, Kai He, Jonathan Sprent, Mark P. Rubinstein
Published in Journal of Hematology & Oncology (2025-02-01)Get full text
Article -
3
Dual targeting of tumoral cells and immune microenvironment by blocking the IL-33/IL1RL1 pathway by Denggang Fu, Hua Jiang, Alan Long, Ella Harris, Hongfen Guo, Maegan L. Capitano, John Wrangle, Joshua R. Faust, Anilkumar Gopalakrishnapillai, Santhosh Kumar Pasupuleti, Baskar Ramdas, Reuben Kapur, Sonali P. Barwe, Nai-Kong V. Cheung, Sophie Paczesny
Published in Nature Communications (2025-07-01)Get full text
Article -
4
724 Subcutaneous nemvaleukin alfa in combination with pembrolizumab in patients with refractory solid tumors (ARTISTRY-2) by Aranzazu Manzano, Omid Hamid, Emiliano Calvo, Marc S Ernstoff, Anthony J Olszanski, John Wrangle, Anthony F Shields, Stephen V Liu, Sarina A Piha-Paul, Trisha M Wise-Draper, Yangchun Du, Justin A Call, Shwetha Asha, Ralph Boccia, Angela Tatiana Alistar, Carlos Mayo, Leah Rider
Published in Journal for ImmunoTherapy of Cancer (2023-11-01)Article -
5
Comparative analysis of antibodies to SARS-CoV-2 between asymptomatic and convalescent patients by Connor J. Dwyer, Colleen A. Cloud, Cindy Wang, Philip Heidt, Paramita Chakraborty, Tara F. Duke, Shannon McGue, Braxton Jeffcoat, Jaclyn Dunne, Logan Johnson, Seungho Choi, Georges J. Nahhas, Amy S. Gandy, Nikolina Babic, Frederick S. Nolte, Philip Howe, Besim Ogretmen, Vamsi K. Gangaraju, Stephen Tomlinson, Brian Madden, Tracy Bridges, Patrick A. Flume, John Wrangle, Mark P. Rubinstein, Prabhakar K. Baliga, Satish N. Nadig, Shikhar Mehrotra
Published in iScience (2021-06-01)Get full text
Article